| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/AID.1997.13.583 |
| P698 | PubMed publication ID | 9135876 |
| P50 | author | Françoise Barré-Sinoussi | Q103844 |
| Saragosti S | Q125312005 | ||
| P2093 | author name string | Muchmore E | |
| Fultz PN | |||
| Georges-Courbot MC | |||
| Georges A | |||
| Girard M | |||
| van der Ryst E | |||
| Dubreuil G | |||
| Nguyen Thi Tuyet H | |||
| P2860 | cites work | Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 |
| High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates | Q33760671 | ||
| Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. | Q34214455 | ||
| CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication | Q34390292 | ||
| Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. | Q35833398 | ||
| Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. | Q35848078 | ||
| Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. | Q35849408 | ||
| The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin | Q35870667 | ||
| Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate | Q36629169 | ||
| Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia | Q36636056 | ||
| Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism | Q36685201 | ||
| Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule | Q36697652 | ||
| Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120 | Q36832017 | ||
| Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1 | Q37239053 | ||
| Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus | Q37375345 | ||
| Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic | Q38889817 | ||
| ??? | Q106873906 | ||
| Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. | Q39090316 | ||
| Genetic variants of HIV-1 in Thailand | Q39234678 | ||
| Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding | Q39485924 | ||
| The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain | Q40060923 | ||
| Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization | Q40308489 | ||
| HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. | Q41223643 | ||
| Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1. | Q41276031 | ||
| Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites | Q41287283 | ||
| The biological phenotype of HIV-1 is usually retained during and after sexual transmission. | Q41436915 | ||
| Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization | Q41478638 | ||
| HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay | Q41646662 | ||
| At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England | Q42686454 | ||
| Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants | Q43707249 | ||
| Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees | Q44246260 | ||
| Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee | Q44515637 | ||
| Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells | Q44761396 | ||
| Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK. | Q44904586 | ||
| Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay | Q45766845 | ||
| Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. | Q45772548 | ||
| HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees | Q45781750 | ||
| Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus | Q45782281 | ||
| Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans | Q45786424 | ||
| Measuring vaccine-induced HIV neutralization: report of a workshop. | Q45947301 | ||
| Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes | Q46377003 | ||
| Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. | Q48078018 | ||
| HIV-1 sequence subtype D in the United States. | Q48083090 | ||
| T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques | Q57997792 | ||
| Recombination in HIV-1 | Q57998149 | ||
| HIV-1 subtypes and male-to-female transmission in Thailand | Q64135029 | ||
| Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolates | Q71515617 | ||
| Detection of diverse HIV-1 genetic subtypes in the USA | Q71520198 | ||
| Antigenic variation in gp120s from molecular clones of HIV-1 LAI | Q71615890 | ||
| Experience from HIV incidence cohorts in Thailand: implications for HIV vaccine efficacy trials | Q72769078 | ||
| Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group | Q112131443 | ||
| P433 | issue | 7 | |
| P921 | main subject | chimpanzee | Q4126704 |
| P304 | page(s) | 583-591 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | AIDS Research and Human Retroviruses | Q4651880 |
| P1476 | title | Characterization and titration of an HIV type 1 subtype E chimpanzee challenge stock | |
| P478 | volume | 13 |
| Q34050742 | Animal models for AIDS pathogenesis |
| Q39579134 | Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS. |
| Q45753184 | Genital infection of female chimpanzees with human immunodeficiency virus type 1. |
| Q37641584 | Minimum infective dose of HIV for parenteral dosimetry |
| Q40819460 | Rectal transmission of human immunodeficiency virus type 1 to chimpanzees |
| Q33810425 | Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques |
Search more.